Avanos Medical (AVNS) Operating Expenses (2016 - 2024)
Historic Operating Expenses for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $81.5 million.
- Avanos Medical's Operating Expenses fell 389.15% to $81.5 million in Q3 2024 from the same period last year, while for Dec 2024 it was $259.3 million, marking a year-over-year decrease of 2840.97%. This contributed to the annual value of $362.2 million for FY2023, which is 182.74% up from last year.
- As of Q3 2024, Avanos Medical's Operating Expenses stood at $81.5 million, which was down 389.15% from $87.2 million recorded in Q2 2024.
- Avanos Medical's 5-year Operating Expenses high stood at $100.5 million for Q1 2020, and its period low was $66.1 million during Q4 2021.
- In the last 5 years, Avanos Medical's Operating Expenses had a median value of $85.9 million in 2022 and averaged $87.6 million.
- As far as peak fluctuations go, Avanos Medical's Operating Expenses tumbled by 2799.56% in 2021, and later surged by 2995.46% in 2022.
- Avanos Medical's Operating Expenses (Quarter) stood at $91.8 million in 2020, then decreased by 28.0% to $66.1 million in 2021, then rose by 29.95% to $85.9 million in 2022, then dropped by 5.36% to $81.3 million in 2023, then rose by 0.25% to $81.5 million in 2024.
- Its Operating Expenses stands at $81.5 million for Q3 2024, versus $87.2 million for Q2 2024 and $90.6 million for Q1 2024.